ALX Oncology Holdings, Inc. (ALXO)
2.45
-0.15
(-5.77%)
USD |
NASDAQ |
Feb 20, 16:00
2.465
+0.02
(+0.61%)
After-Hours: 20:00
ALX Oncology Holdings EPS Diluted (Quarterly) : -0.4133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Coherus Oncology, Inc. | -0.3021 |
| Century Therapeutics, Inc. | -0.3981 |
| Climb Bio, Inc. | -0.1895 |
| PepGen Inc. | -0.5246 |
| Fortrea Holdings, Inc. | -0.1743 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.14M |
| Total Expenses (Quarterly) | 22.14M |
| Enterprise Value | 276.41M |
| Earnings Yield | -82.76% |
| Normalized Earnings Yield | -81.06 |